New Annual list filed for AMBS today. Simple, just for good standing with Nevada SoS, but curious. They filed one on 3/13/21 as well. As reported then, these are expensive and not done just to satisfy a law. Previous to these two, there had been no new filings since 2019. As some twitter bot reported, OTC page is receiving updates too, with an oddly times O/S update (still no dilution). The description has also updated with and Eltoprazine focus.
(3)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links